Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRAF | P15056 | 6/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.30 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.30 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7002452 | 0.91 | ALOX5AP (0.33) | BRAFALOX5APFEN1PDE3BPDE3A | |
| SCHEMBL6994325 | 0.90 | BRAF (0.34) | BRAFARALOX5APFEN1PDE3B | |
| SCHEMBL6999522 | 0.88 | PGR (0.33) | — | |
| SCHEMBL6999842 | 0.87 | BRAF (0.36) | BRAFAR | |
| SCHEMBL6997789 | 0.84 | PTGS2 (0.34) | — | |
| SCHEMBL6999756 | 0.83 | PTGS2 (0.42) | PDE3BPDE3A | |
| SCHEMBL7002037 | 0.83 | BRAF (0.35) | BRAFPDE3BPDE3AMALT1 | |
| SCHEMBL6995210 | 0.82 | BRAF (0.39) | BRAF | |
| SCHEMBL6999608 | 0.82 | BRAF (0.41) | BRAF | |
| SCHEMBL7004400 | 0.81 | PDE3B (0.36) | BRAFALOX5APFEN1PDE3BPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1109799-B1 | 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | PACIFIC CORP (KR) | 2003-12-17 | — | — | EP | claimed |
| US-6492416-B1 | TREATING INFLAMMATION AND ASSOCIATED DISORDERS | PACIFIC CORPORATION (KR) | 2002-12-10 | — | — | US | claimed |
| EP-1109799-B1 | 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | PACIFIC CORP (KR) | 2003-12-17 | — | — | EP | disclosed |
| US-6492416-B1 | TREATING INFLAMMATION AND ASSOCIATED DISORDERS | PACIFIC CORPORATION (KR) | 2002-12-10 | — | — | US | disclosed |